Literature DB >> 17606545

Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement.

.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17606545     DOI： 10.1542/peds.2006-1812

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  22 in total

1.  Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study.

Authors:  John A Morrison; Charles J Glueck; Ping Wang
Journal:  Metabolism       Date:  2011-10-14       Impact factor: 8.694

2.  Screening for familial hypercholesterolaemia.

Authors:  Ned Calonge; Janelle Guirguis-Blake
Journal:  BMJ       Date:  2007-09-22

3.  Using body mass index data in the electronic health record to calculate cardiovascular risk.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Sheryl Catz; Paul A Fishman; Jennifer B McClure; Robert Reid
Journal:  Am J Prev Med       Date:  2012-04       Impact factor: 5.043

4.  Early ventricular remodeling and dysfunction in obese children and adolescents.

Authors:  Aura A Sanchez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

5.  The child as proband for future parental cardiometabolic disease: the 26-year prospective Princeton Lipid Research Clinics Follow-up Study.

Authors:  John A Morrison; Charles J Glueck; Ping Wang
Journal:  J Pediatr       Date:  2012-01-13       Impact factor: 4.406

6.  Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV.

Authors:  Suad Kapetanovic; Lisa Aaron; Paige L Williams; John Farley; Patricia A Sirois; Patricia A Garvie; Deborah A Pearson; James M Oleske; Grace Montepiedra
Journal:  Neurobehav HIV Med       Date:  2010-08

7.  Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age.

Authors:  Agnes Langat; Sarah Benki-Nugent; Dalton Wamalwa; Ken Tapia; Evelyn Ngugi; Lara Diener; Barbra A Richardson; Ann Melvin; Grace C John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

8.  Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Authors:  Katherine Tassiopoulos; Paige L Williams; George R Seage; Marilyn Crain; James Oleske; John Farley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

9.  The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.

Authors:  Costan G Magnussen; Alison Venn; Russell Thomson; Markus Juonala; Sathanur R Srinivasan; Jorma S A Viikari; Gerald S Berenson; Terence Dwyer; Olli T Raitakari
Journal:  J Am Coll Cardiol       Date:  2009-03-10       Impact factor: 24.094

10.  Short-term change in body mass index in overweight adolescents following cholesterol screening.

Authors:  Nipa Doshi; Eliana M Perrin; Suzanne Lazorick; Denise Esserman; Michael J Steiner
Journal:  Arch Pediatr Adolesc Med       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.